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Several melanosome membrane proteins have been
identified, forming a family of proteins known as
tyrosinase related proteins. Human TRP-1/gp75 is sorted
to melanosomes through the endoplasmic reticulum and
Golgi complex to the endocytic pathway, directed by
a sorting signal located in the cytoplasmic tail. This
hexapeptide cytoplasmic sequence, which is conserved
in the tyrosinase related protein family and through
vertebrate evolution, was shown to act also as a sorting
signal in mouse gp75, confirming that its sorting and
cellular retention function is conserved between human
and mouse. The cytoplasmic tail influenced the rate and
efficiency of intracellular transport of gp75 from the
Biogenesis of cytoplasmic organelles requires targeting ofsoluble and membrane proteins to appropriate vesicularprecursors. The melanosome is a melanocyte specific,intracellular organelle that is specialized for melaninsynthesis. Several melanosomal membrane proteins have
been identified, including three members of the tyrosinase related
proteins (TRP) family, tyrosinase, TRP-1/gp75, and TRP-2 (Shibahara
et al, 1986; Kwon et al, 1987; Jackson, 1988; Bouchard et al, 1989;
Vijayasaradhi et al, 1990; Jackson et al, 1992; Tsukamoto et al, 1992).
Gp75 is one of the best characterized melanoma differentiation antigens
(Houghton et al, 1987; Vijayasaradhi et al, 1990; Houghton, 1994).
Gp75 is encoded by the brown locus, one of the loci that determines
mouse coat color. It is the most abundant glycoprotein in melanocytes
and a member of the TRP family of proteins (Tai et al, 1983;
Vijayasaradhi and Houghton, 1991). Gp75 has 5,6-dihydroxyindole-
2-carboxylic acid oxidase activity that catalyzes an intermediate step in
the melanin synthesis pathway (Jimenez-Cervantes et al, 1994). Our
previous studies of human gp75 have identified an intracellular sorting
and retention signal in the cytoplasmic tail of human gp75, comprising
asn-gln-pro-leu-leu-thr hexapeptide sequence (Vijayasaradhi et al,
1995). This signal is necessary for sorting melanosomal membrane
proteins to the endosomal/lysosomal pathway (Vijayasaradhi et al, 1995).
Autoantibodies against gp75 have been found in the sera of melanoma
patients, and mice bearing antibodies against gp75, either passively
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endoplasmic reticulum to the cis-Golgi. Deletion of 33
or 27 amino acids from the carboxyl end of the 38 amino
acid cytoplasmic tail of gp75 caused retention and rapid
degradation of the truncated gp75 in the endoplasmic
reticulum. This defective movement could be fully
corrected by extending the truncated tail with the
unrelated cytoplasmic tail of the low density lipoprotein
receptor. Thus, the cytoplasmic tail of mouse gp75 not
only determines sorting to the endocytic/melanosomal
compartment, but also controls export from the
endoplasmic reticulum to Golgi. Key words: endoplasmic
reticulum/endosomes/lysosomes/melanosome/mutagenesis.
J Invest Dermatol 110:324–331, 1998
transferred with monoclonal antibodies or actively induced by
immunization, reject melanoma metastases (Mattes et al, 1983; Hara
et al, 1995; Naftzger et al, 1996). Cytotoxic and helper T cells specific
for tyrosinase and a product encoded by an alternative transcript of
the brown locus have been detected in melanoma patients (Cox et al,
1994; Robbins et al, 1994; Topalian et al, 1994; Wolfel et al, 1994; Wang
et al, 1996). The intracellular transport to the endocytic compartment of
proteins in this family is relevant both for understanding melanosome
biogenesis and for elucidating antigen processing and presentation
pathways of these proteins to the immune system.
Mouse and human gp75 share more than 80% amino acid sequence
homology. In particular, the hexapeptide sequence implicated as a
sorting signal on human gp75 is conserved in the cytoplasmic tail of
mouse gp75 as well as other vertebrate homologs of TRP-1, but it is
not known if this signal is functional in these other species. In this
study, we investigated the role of the cytoplasmic tail of mouse gp75
in sorting and stability of the protein, and confirm that the cytoplasmic
tail contains an intracellular retention signal. More importantly, the
cytoplasmic tail determines the intracellular transport of gp75 from the
endoplasmic reticulum (ER) to the Golgi compartment, affecting the
intracellular stability of the protein. This transport could be corrected
by replacing the gp75 cytoplasmic tail with an unrelated stretch of
amino acids from the cytoplasmic tail of the cell surface receptor for
low density lipoprotein. Thus, the cytoplasmic tail of gp75 has multiple
functions that determine trafficking throughout the secretory pathway,
including not only endocytic sorting but also export from the ER.
MATERIALS AND METHODS
Cell lines and antibodies B16F10 is a mouse melanoma cell line kindly
provided by Isaiah Fidler (MD Anderson Cancer Center, Houston, TX) (Fidler,
1975) and the mouse L929 fibroblast cell line was obtained from the American
Type Culture Collection (Rockville, MD). These cell lines were grown and
VOL. 110, NO. 4 APRIL 1998 SORTING AND TRANSPORT OF GP75 325
Figure 1. (A) Schematic diagram of mouse gp75 cDNA showing partial
restriction sites. The numbers indicate nucleotide sequence positions (translation
starts at 1). 59UT, 59 untranslated region; 39UT, 39 untranslated region; ORF,
open reading frame; *, restriction site generated by site directed mutagenesis.
(B) Schematic diagram of amino acid sequences of wild-type gp75 and different
gp75 variants showing the protein domains and structural features. SP, signal
peptide; TM, transmembrane region; Cyt, cytoplasmic tail. Numbers indicate
amino acid positions.
passaged in culture as described (Bouchard et al, 1989; Vijayasaradhi et al, 1991).
Purified mouse monoclonal anti-human and mouse gp75 antibody TA99 was
described earlier (Vijayasaradhi et al, 1990). Fluoroscein isothiocyanate (FITC)
conjugated rabbit anti-mouse IgG was from Dako (Carpinteria, CA).
Plasmid construction Schematic diagrams showing features of the cDNA
sequence and the protein sequence of wild-type and mutant gp75 molecules
described in this study are shown in Fig 1. An 1.8 kb EcoRI fragment
containing the full length mouse gp75 cDNA was isolated from pMT4 plasmid
(kindly provided by Dr. T. Shibahara, Tohoku University School of Medicine,
Japan), and subcloned into the unique EcoRI site of eukaryotic expression
vector pSVK3.1 to generate pSVK3.1-mgp75. pSVK3.1 is a derivative of
pSVK3 (Pharmacia LKB Biotechnology, Piscataway, NJ), modified by removing
the Sac I fragment within the multiple cloning sites. The orientation of the
insert was determined by restriction enzyme analysis and confirmed by DNA
sequencing using Sequenase Kit (US Biochemicals, Cleveland, OH). Mutant
constructs were was made as described below.
gp75D27 A new, unique restriction site NaeI was generated on pSVK3.1-
mgp75 at nucleotide sequence 1705 using oligonucleotide directed mutagenesis
(see below). The plasmid was then digested with NaeI, and religated in the
presence of the suppressible reading frame termination (SMURFT) linker. This
resulted in a deletion of 27 amino acids from the cytoplasmic tail of mouse
gp75 and an addition of a novel Leu-Ala-Ala sequence, encoded from the
stop linker.
gp75D33 pSVK3.1-mgp75 was digested with restriction enzyme Xba I for 15–
30 min with low enzyme:DNA ratio to result in partial digestion. Under this
condition, a major portion of the plasmid was cleaved at only one of two Xba
I sites (nucleotide sequence 573 and 1681) to give rise to a linear fragment.
After a fill-in reaction with Klenow fragment of DNA polymerase I, this linear
fragment was isolated and ligated with a SMURFT linker, 59 CTAG-
CTAGCTAG 39 (Pharmacia, Piscataway, New Jersey). Plasmids with an insertion
of the SMURFT linker at position 1681 were selected by restriction enzyme
digestions and DNA sequencing. This manipulation resulted in conversion of
Arg (AGA) at position 504 (amino acids numbered starting with the methionine
codon at nucleotide sequence 175 as the initiation codon) to Ser (AGC) in the
amino acid sequence, and translation termination at position 505. Thirty-three
of 36 amino acids from the carboxyl terminus of mouse gp75 were deleted in
this mutant construct.
Gp75D55 pSVK3.1-mgp75 plasmid was digested with restriction enzyme Xcm
I, treated with T4 DNA polymerase to remove the 39 overhangs, and religated
in the presence of the SMURFT linker. This resulted in an alteration of amino
acid codon GCT to GCC at position 482, both of which encode Ala, and a
translation stop codon at position 483. Fifty-five amino acids were deleted from
the carboxyl terminus of mouse gp75, including the entire cytoplasmic tail and
19 of the 24 amino acids from the transmembrane region.
gp75D27-LDL The mutagenized pSVK3.1 1 mgp75 containing NaeI site was
linearized with NaeI digestion. The linear plasmid was then ligated with a
double stranded DNA fragment annealed from two complementary oligo-
nucleotide chains, 59 AACCCAGTCTACCAGAAGACCTAGTACT 39 and
59 AGTACTAGGTCTTCTGGTAGACTGGGTT 39. This double stranded
DNA fragment encodes seven amino acids NPVYQKT, which are present in
the cytoplasmic tail of mouse low density lipoprotein (LDL) receptor. This
resulted in deletion of the last 27 amino acids from the cytoplasmic tail of gp75
and an addition of NPVYQKT downstream to the truncated tail. The underlined
regions of the sequence represent incorporated ScaI sites for subsequent screening
of the recombinant DNA clones. The orientation of the insert was determined
by restriction enzyme analysis and confirmed by DNA sequencing.
Site directed mutagenesis The Muta-gene Phagemid in vitro mutagenesis
kit (Bio-Rad, Melville, NY) was used to create a new NaeI site at nucleotide
sequence 1705. OLXU 22 59 AGTGAGGAGAGGCTGGCCGGCTTCA-
TTCTT 39, complementary to nucleotide 1694–1723 in gp75 cDNA, contains
nucleotide substitution from TT→CC, necessary to create a NaeI site. Mutants
were screened and identified by DNA sequencing.
Transfection and isolation of stable gp75 expression clones Mouse L
cell fibroblasts were transfected with plasmid containing full length or mutant
gp75 cDNA and pSV2 neo using calcium phosphate precipitation method. The
transfectants were selected for growth in medium containing 500 µg antibiotic
Geneticin per ml (GIBCO BRL, Grand Island, NY). Individual transfectant
clones were isolated using cloning rings (Bellco, Vineland, NJ) and screened
for gp75 expression by immunofluorescence staining with monoclonal antibody
(MoAb) TA99.
Metabolic cell labeling and cell surface labeling, immunoprecipitation
and electrophoresis, and cell extraction The metabolic labeling and
immunoprecipitation was done as described (Vijayasaradhi et al, 1991). Briefly,
cells were metabolically labeled with [35S]methionine (EXPRE35S35S protein
labeling mix; NEN Du Pont, Boston, MA). For pulse chase experiments, cells
were labeled with 50 µCi of [35S]methionine per ml medium per 4–5 3 106
cells for 10–15 min, washed twice with phosphate buffered saline (PBS), and
chased in medium containing nonradiolabeled methionine for indicated periods.
Cells were lyzed in lysis buffer containing 10 mM Tris/HCl, pH 7.5, 5 mM
ethylenediamine tetraacetic acid, 1% NP40, 0.5% deoxycholate, 150 mM NaCl,
2 µg aprotinin per ml, 0.7 µg pepstatin per ml, 0.5 mg leupeptin per ml,
and 0.2 mM phenylmethylsulfonyl fluoride. In the pulse chase experiments,
normalization of the protein amount in each chase point was based on the
measurement of the trichloroacetic acid insoluble (trichloroacetic acid) counts
in the cell lysate from incorporation of [35S] methionine into proteins.
Appropriate volumes of cell lysates representing equal amounts of trichloroacetic
acid insoluble cpm from each sample were taken for subsequent antibody
incubation. The lysate was incubated with MoAb TA99 at 4 µg per ml final
concentration for 1 h to overnight at 4°C followed by incubation with Protein
A sepharose (10% wt/vol) (Pharmacia, Piscataway, NJ) for 2 h to overnight at
4°C. The immunoprecipitates were washed five times with 10 mM Tris/HCl,
pH 7.5, 150 mM NaCl, 5 mM ethylenediamine tetraacetic acid, and 1% NP-
40 (TNEN), five times with one-tenth strength TNEN containing 0.5 M NaCl
and finally one time with distilled H2O. Proteins were analyzed by 9% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Radioactive
protein bands were visualized by fluorography on Kodak XAR film (Rochester,
NY) using Amplify (Amersham, Arlington Heights, IL).
Triton X-114 extraction was done exactly as described (Bordier, 1981). For cell
surface iodination, cells were surface labeled with 125I using the lactoperoxidase
method (Morrison, 1980) with slight modifications. Briefly, after washing cells
grown on 100 mm Petri dishes twice with PBS, 0.5 ml labeling mixture
containing 5 U lactoperoxidase (Calbiochem, La Jolla, CA) and 500 µCi of
Na125I (NEN Du Pont, Boston, MA) in PBS was added to each sample. Two
microliters of diluted H2O2 (1:10,000) was then added four times at 4 min
intervals. Cell lysis and immunoprecipitation were performed in the same way
as with [35S]methionine labeled experiments. After separation on a SDS-PAGE
gel, 125I labeled protein bands were visualized by autoradiography.
Endoglycosidase H (Endo H) digestion Immunoprecipitated samples were
suspended in 30 µl 0.4% sodium dodecyl sulfate, heated for 4 min at 100°C,
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and diluted with 30 µl 0.1 M sodium citrate buffer, pH 5.5. Endo H was added
to the samples at a final concentration of 100–150 mU per ml and the reaction
was carried out at 37°C for 18–24 h. Seventy microliters of toluene was added
on the top of the reaction mixture during incubation. Control samples were
treated the same way except that no Endo H was added.
Immunofluorescence cell staining and microscopy Cells were allowed
to grow on chamber slides (Nunc, Naperville, IL) overnight, fixed with 2%
formaldehyde in PBS for 10 min, and permeabilized with cold methanol on
ice for 90 s. Cells were then incubated with MoAb TA99 (4 µg per ml) in
0.15% saponin in PBS for 30 min, washed with PBS, and incubated with FITC
conjugated rabbit anti-mouse IgG (Dako) for 30 min. For staining of cell surface
proteins, cells were washed with ice cold PBS, incubated with MoAb TA99
and FITC conjugated rabbit anti-mouse IgG in cold PBS on ice. At the end
of the staining, cells were fixed in 2% formaldehyde for 10 min. After mounting
in PBS with 80% glycerol and 1 mg of ρ-phenylenediamine per ml (Sigma),
the cells were viewed with a 340 oil Planapo lens on a Nikon (Tokyo, Japan)
Optiphot microscope and photographed using Kodachrome film.
RESULTS
Intracellular movement and stability of full length mouse
gp75 Mouse gp75 cDNA encodes a 537 amino acid long polypeptide.
It consists of a 24 amino acid long N-terminal signal peptide sequence,
a long amino terminal domain, a 24 amino acid transmembrane region,
and a 36 amino acid carboxyl/cytoplasmic terminal domain (Fig 1B).
Indirect immunofluorescence staining of gp75 in B16 melanoma cells
with MoAb TA99 showed that gp75 is localized to juxtanuclear regions
and distinct cytoplasmic vesicles in melanocytic cells (Fig 2a). The
punctate cytoplasmic staining represented melanosomes and their
precursors based on immunoelectron microscopic analysis,
demonstrating that MoAb TA99 specifically recognizes gp75 in
melanosomes (Thomson et al, 1988; Vijayasaradhi et al, 1995). The
juxtanuclear staining is consistent with staining of Golgi complexes
and endosomes, indicating a natural transport of gp75 through the
Golgi apparatus and endocytic compartment.
To investigate the structural requirements for intracellular sorting
and targeting of gp75 with special attention to the cytoplasmic tail, we
used an L cell fibroblast transfection system. We generated gp75
cytoplasmic tail deletion mutants, and studied the subcellular
distribution, the time course of intracellular transport, and the stability
of full length and mutant gp75 proteins.
To establish a baseline, we first evaluated the sorting and stability of
full length gp75 cDNA transfected in L cell fibroblasts compared
with gp75 expressed in B16 melanoma cells (Figs 2, 3). Indirect
immunofluorescence localization of full length gp75 in transfectants
showed intense juxtanuclear staining and punctate cytoplasmic vesicular
staining, visually indistinguishable from that of B16 melanoma staining
(Fig 2a, b). This pattern is also identical to the staining pattern of
human full length gp75 expressed in human melanocytic cells and L
cell fibroblasts (Vijayasaradhi et al, 1995). These punctate vesicles are
presumably endosomes/lysosomes, based on previous findings from
colocalization studies in human melanoma cells where these structures
express both gp75 and the endosomal/lysosomal resident protein
LAMP-1 (Orlow et al, 1993; Winder et al, 1993; Vijayasaradhi et al,
1995). Thus, murine full length gp75 is retained intracellularly in a
vesicular compartment in fibroblast transfectants, presumably due to a
retention and sorting signal in the protein that directs it to the endocytic
compartment.
We compared the time course of biosynthesis and processing of
gp75 in fibroblasts and melanocytic cells (Fig 3). B16 melanoma cells
and L cell transfectants expressing full length gp75 (wtgp75) were
metabolically labeled with [35S]methionine for 10 min and chased for
different amounts of time. The cell lysates were immunoprecipitated
with MoAb TA99, and half of the sample at each chase point was
subjected to Endo H digestion. At the end of a 10 min pulse and after
15 min chase, newly synthesized gp75 appeared as a 71 kDa band in
melanoma cells and L cell transfectants (L cell transfectants expressed
an additional 65 kDa band that will be discussed below), and all bands
were sensitive to Endo H digestion. Because Endo H removes high-
mannose oligosaccharide chains from glycoproteins processed in the
ER or cis-Golgi, the sensitivity of these proteins to Endo H digestion
Figure 2. Subcellular localization of gp75 in B16 melanoma cells and L
cell transfectants by immunofluorescence microscopy analysis. B16
melanoma cells (a) and L cell transfectants expressing wild-type gp75 (b) and
gp75 ∆33 (c, d, e, and f) were plated on chamber slides and allowed to adhere
overnight. After fixation in 2% formaldehyde and permeabilization in methanol
(a, b, d, and f) or without any fixation or permeabilization (c and e), the cells
were stained with MoAb TA99 (a, b, e, and f) or isotype matched control
MoAb UPC10 (c and d) followed by FITC conjugated anti-mouse IgG at room
temperature. Scale bars, 5 µm.
indicated that the newly synthesized proteins had not moved past an
ER/pre-Golgi compartment at these time points. Starting from the
end of a 30 min chase, the 71 kDa form began to increase in molecular
mass, appearing as a 75–82 kDa band in B16 melanoma cells and a
72–79 band in fibroblast transfectants; these new bands became partially
resistant to Endo H digestion. The increase in molecular mass and
conversion from an Endo H sensitive to an Endo H resistant form
reflected the forward movement of gp75 from the ER or cis-Golgi to
the medial- and trans- Golgi apparatus, and maturation of gp75 due to
processing to complex sugar moieties in the Golgi compartments. The
kinetics of this step occurred between 30 min and 1 h after synthesis
and were similar in both cell lines. Judging from the intensity of the
gp75 bands, mature gp75 had identical stabilities in the two cell types
(L cells and B16 melanoma cells). A pulse chase experiment with
longer chase intervals showed that the half-life of mature gp75 was 4–
8 h in both cell types (data not shown).
Taken together, the above data established that the rate of
biosynthesis, intracellular transport, and stability of gp75 expressed in
the fibroblasts is indistinguishable from that in melanoma cells. The
slightly different molecular masses of mature gp75 detected in the two
cell types (the 75–82 kDa band in B16 cells and the 72–79 kDa band
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Figure 3. Kinetic analysis of biosynthesis and transport of gp75 in
mouse melanoma cells and L cell transfectants expressing wild-type
gp75. Cells were pulse labeled with [35S]methionine for 10 min and chased
for the indicated periods of time. Gp75 protein was immunoprecipitated from
the cell lysate with MoAb TA99. Half of the immunoprecipitate from each
lysate sample was digested with Endo H (1), whereas the other half was not
(–). The immunoprecipitated proteins were analyzed on a 9% SDS-PAGE
gel. Numbers on the left side are apparent molecular masses (kDa) of the
marker bands.
in L cells) was due to different levels of glycosylation, because N-
glycanase digestion to remove all N-linked oligosacharides yielded an
identical 57 kDa core polypeptide for both cell types (data not shown).
The additional 68 kDa band found in transfectants was identified as a
truncated form of gp75 lacking the cytoplasmic tail and the
transmembrane region, based on reactivity with antibody against the
C-terminal domain and peptide mapping data (Xu et al, 1997). A
smaller carboxyl truncated form of endogenous gp75 can also be
detected in B16 mouse melanoma cells in some experiments (Xu et al,
1997). Thus, gp75 can be processed by post-translational proteolysis
in both mouse melanoma cells and fibroblasts, and this effect is not
simply an artifact of fibroblast transfectants.
An intracellular retention signal is located in the cytoplasmic
tail of mouse gp75 To investigate the structural requirements for
intracellular sorting and transport, we constructed two gp75 variants
with deletions in the cytoplasmic tail, designated gp75∆27 and gp75∆33,
where 27 or 33 amino acids from the proposed 36 amino acid
cytoplasmic tail were deleted (Fig 1B). These mutant DNA constructs
were transfected and expressed in L cell transfectants and stable clones
were established. Cellular localizations of these mutant gp75 variants
were studied by indirect immunofluorescence staining with MoAb
TA99 (Fig 2e, f). Staining of live gp75∆33 transfectants showed a
peripheral ring-like pattern that demarcated the cellular margins,
consistent with plasma membrane localization (Fig 2e), a pattern not
seen in control unfixed cells (Fig 2c). After fixation and
permeabilization, these cells showed an intensive staining of the cell
plasma membrane along with a diffuse staining over the cell body and
occasional patches near the cell margins (Fig 2f), with no specific
staining in control, fixed cells (Fig 2d). In contrast to the staining
pattern of full length gp75 in B16 melanoma cells and transfectants
(Fig 2a, b), no cytoplasmic punctate vesicular staining or juxtanuclear
staining was observed (Fig 2f). The immunofluorescence staining of
gp75∆27 transfectants showed a nearly identical pattern (data not
shown). These results showed that gp75∆33 and gp75∆27 proteins
Figure 4. Gp75∆55 is soluble and secreted in transfectants. (A) Gp75∆55
is soluble. Triton X-114 extraction of gp75∆55 protein expressed in L cell
transfectants. Cells were labeled with [35S]methionine for 1 h and lyzed. The
cell lysate was subjected to Triton X-114 separation. Gp75 protein extracted
into the aqueous phase (A) or detergent phase (D) was then immunoprecipitated
with MoAb TA99. (B) Gp75∆55 is secreted. L cells expressing gp75∆55 were
pulse labeled with [35S]methionine for 10 min and chased for the indicated
periods of time. Gp75∆55 protein was immunoprecipitated from both the cell
lysate and the cell medium with MoAb TA99. The immunoprecipitated proteins
were analyzed on a 9% SDS-PAGE gel. Numbers on the left side are apparent
molecular masses (kDa) of the marker bands.
have a predominant cell surface expression pattern. This cell surface
staining could not be detected in either melanoma cells or full length
gp75 transfectants after careful examination, indicating that full length
gp75 is not normally expressed at detectable levels in the plasma
membrane using in situ immunofluorescence staining (although more
sensitive techniques can detect cell surface expression) (Takechi et al,
1996; Xu et al, 1997). Because gp75 mutants lacking the cytoplasmic
tail, particularly the last 27 amino acids, were expressed on the cell
surface instead of being retained in vesicular compartments within the
cell, the last 27 amino acids in the cytoplasmic tail of mouse gp75
contain a signal for intracellular retention.
To further confirm the above results and to examine whether the
lumenal portion of the protein contains additional lysosomal sorting
signals (such as mannose-6-phosphate normally used for sorting soluble
lysosomal enzymes; Dahms et al, 1989), we constructed another gp75
deletion variant, gp75∆55, which lacks the entire cytoplasmic tail and
19 of 24 amino acids in the transmembrane domain (Fig 1B). Although
five hydrophobic amino acid residues remained in the transmembrane
region, the gp75∆55 protein was soluble and not membrane bound,
based on a Triton X-114 extraction experiment (Fig 4A). Cellular
gp75∆55 partitioned mainly to the aqueous phase. Some of the
gp75∆55 protein was secreted (Fig 4B). At the end of 15 min chase,
a 68 kDa early secretory form of gp75 appeared in the supernatant.
This band was sensitive to Endo H digestion, was stable in the
supernatant, and could be detected at 24 h of chase (data not shown).
Interestingly, a 72 kDa late secretory form of gp75∆55 appeared after
a chase of 4 h. We have previously characterized a secretory form of
gp75 that is expressed physiologically in B16 mouse melanoma cells
(Xu et al, 1997). Because the 72 kDa secretory form showed resistance
to Endo H digestion (data not shown), this band represented a mature
gp75∆55 form, being transported and processed through the Golgi
apparatus. This late secretory form was very stable, similar to gp75
secreted from B16 melanoma cells, with a half-life . 20 h (Xu et al,
1997; and data not shown). Because the 72 kDa late secretory form of
gp75∆55 could not be detected at any chase point in the cell lysate, it
indicated that the late secretion of mature gp75∆55 is rapid after its
processing in the Golgi. The secretion of gp75∆55 supports the notion
that only the cytoplasmic tail contains a signal for endosomal/lysosomal
328 XU ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 5. Subcellular localization of mutant gp75 in L cell transfectants
by immunofluorescence microscopy analysis. L cell transfectants expressing
gp75∆55 (A) and gp75∆27-LDL (B) were fixed and permeabilized as described
in the legend for Fig 2. The cells were then stained by MoAb TA99 followed
by staining with FITC conjugated anti-mouse IgG. Long white arrows show cell
surface staining and short white arrows demonstrate perinuclear staining. Scale
bars, 5 µm.
sorting and transport. Thus, no additional intracellular retention signal
was detected in the lumenal portion of gp75, based on these results
showing that gp75 without a cytoplasmic tail moves through the
secretory pathway without any intracellular retention (Xu et al, 1997).
Although a proportion of gp75∆55 was secreted, most gp75∆55 was
degraded intracellularly in the ER. The amount of secretory forms of
gp75 recovered in the supernatant at 4 h chase was only µ10% of the
total gp75 protein. The reduction in the amount of cellular gp75∆55
between 4 and 8 h chase was much more than the increase in secreted
gp75∆55. Cellular gp75∆55 appeared as a 65 kDa band, remained
sensitive to Endo H digestion, and displayed a half-life of 4–8 h. The
continued sensitivity to Endo H of cellular gp75∆55 is consistent with
degradation occurring in the ER or a pre-Golgi compartment.
Immunofluorescence staining of gp75∆55 transfectants using MoAb
TA99 showed a fine cytoplasmic reticular staining. No juxtanuclear
staining or punctate vesicular staining was detected, nor was there
ring-like plasma membrane staining (Fig 5A). This staining pattern
was consistent with localization of gp75∆55 in the ER, which supports
the above biochemical data showing that cellular gp75∆55 was retained
in the ER. Because a fraction of newly synthesized gp75∆55 did go
through the Golgi apparatus, the lack of juxtanuclear staining supported
the biochemical results that transport through the Golgi is rapid,
probably due to brisk secretion, and there is little accumulation in
the Golgi.
The cytoplasmic tail of gp75 determines export from the
ER of gp75 Because the above pulse chase analysis of gp75∆55
transfectants showed defective intracellular transport of a major
proportion of gp75∆55, leading to ER retention, we examined the
time course of cellular transport of gp75∆33 (Fig 6A) and gp75∆27
(data not shown) proteins. At the end of 10 min labeling, gp75∆33
protein appeared as a broad 65–68 kDa band, which was sensitive to
Endo H digestion (Fig 6A). This broad band continued to be detected
during the chase period for up to 16 h, although the intensity of the
band decreased by about one-half by 4 h of chase (i.e., half-life , 4 h).
At the end of 4 h chase, a minor 74 kDa band was detected (Fig 6A,
B). Like the 72 kDa form of mature secretory gp75∆55, this band
showed resistance to Endo H digestion, representing a small proportion
of gp75∆33 having gone through processing in the medial- or trans-
Golgi apparatus. Unlike the short-lived 65–68 kDa band, this 74 kDa
form was more stable with a half-life . 12 h (Fig 6A). Pulse chase
analysis of gp75∆27 revealed similar results (data not shown). Thus, in
all three gp75 variants that lacked a portion or all of the cytoplasmic
tail, only a very small proportion of newly synthesized protein was
able to move out of the ER to the Golgi apparatus, whereas most
newly synthesized truncated gp75 was retained and degraded in the ER.
To confirm that only the mature 74 kDa form of gp75∆33 was
transported to the cell surface, we labeled cell surface proteins using
125I-lactoperoxidase followed by immunoprecipitation with MoAb
TA99 (Fig 6C). The cell surface form of gp75∆33 was 74 kDa, and
Figure 6. A portion of newly synthesized gp75∆33 protein is transported
through the Golgi apparatus and expressed on the cell surface. (A)
Kinetic analysis of biosynthesis and transport of gp75∆33 in L cell transfectants.
L cells expressing gp75∆33 were pulse labeled with [35S]methionine for
10 min and chased for the indicated periods of time. Gp75∆33 protein was
immunoprecipitated from the cell lysate with MoAb TA99. Half of the
immunoprecipitate from each lysate sample was digested with Endo H (1)
whereas the other half was not (–). The closed arrows indicate the mature 74 kDa
gp75∆33 protein, and the open arrows indicate the Endo H resistant form of
mature gp75∆33. (B) Specificity of precipitation of the mature 74 kDa gp75∆33
protein. L cells expressing gp75∆33 were pulse labeled with [35S]methionine
for 10 min, followed by no chase or chase for 8 h. Lysates were
immunoprecipitated with either MoAbTA99 or control MoAbUPC10. The
closed arrow indicates the mature 74 kDa gp75∆33 protein specifically
immunoprecipitated by MoAb TA99. Numbers on the right side are apparent
molecular masses (kDa) of the protein bands. (C) Gp75∆33 expressed on the
cell surface is mature gp75 after processing in the Golgi apparatus. L transfectants
expressing gp75∆33 were surface labeled with 125I by lactoperoxidase method.
Gp75 protein was immunoprecipitated using MoAb TA99. Half of the
immunoprecipitate in each sample was digested with Endo H (1), whereas the
other half was not (–). The immunoprecipitated proteins were analyzed on a
9% SDS-PAGE gel. Numbers on the left side are apparent molecular masses
(kDa) of the protein bands.
was resistant to Endo H digestion. This result confirmed that cell
surface gp75∆33 was post-translational processed in the medial- and
trans-Golgi.
Taken together, these data confirmed that gp75 molecules with
deletions of the cytoplasmic tail were almost completely unable to
leave the ER. A potential export signal for vesicular transport from
the ER presumably exists in the carboxyl 27 amino acids of gp75 (see
Discussion).
Extension of the cytoplasmic tail by seven amino acids from
the cytoplasmic tail of the LDL receptor restores efficient
transport of gp75 To examine how the cytoplasmic tail influenced
stability of gp75 in the ER, we tested whether extending the cytoplasmic
tail with an unrelated sequence that did not contain the melanosome/
endosome sorting signal could restore the efficient export of gp75 out
of the ER. A chimeric molecule gp75∆27-LDL was constructed by
ligating a DNA fragment encoding Asn-Pro-Val-Tyr-Gln-Lys-Thr to
the restriction enzyme site Nae I of gp75∆27 cDNA (Fig 1B). This
seven amino acid sequence was taken from the cytoplasmic tail of a
cell surface protein, the mouse LDL receptor (Polvino et al, 1992).
Pulse chase analysis of transfectants expressing this chimeric protein
showed that, at the end of 15 min labeling, the newly synthesized
chimeric protein appeared as a doublet of 70 kDa and 72 kDa. By the
end of 1 h, most of the 72 kDa form increased in molecular mass and
gained Endo H resistance (Fig 7). This kinetics of movement from
the ER to the Golgi complex were similar to that of wild-type
gp75 (Fig 3).
The intracellular localization of gp75∆27-LDL was studied by
indirect immunofluorescence staining (Fig 5B). Fixed and
permeabilized gp75∆27-LDL transfectants revealed staining of the
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Figure 7. Kinetic analysis of biosynthesis and transport of gp75∆27-
LDL in L cell transfectants. L cells expressing gp75∆27-LDL were pulse
labeled with [35S]methionine for 10 min and chased for the indicated periods
of time. Gp75∆55 protein was immunoprecipitated from the cell lysate with
MoAb TA99. Half of the immunoprecipitate from each lysate sample was
digested with Endo H (1), whereas the other half was not (–). The
immunoprecipitated proteins were analyzed on a 9% SDS-PAGE gel. Numbers
on the left side are apparent molecular masses (kDa) of the marker bands.
plasma membrane (long white arrows in Fig 5B). An intense staining of
juxtanuclear patches was also seen (short white arrows in Fig 5B),
supporting the biochemical data showing movement of gp75∆27-LDL
through the Golgi apparatus. This observation is similar to slow
transport through the Golgi shown by full length gp75 (Fig 2a, b).
There was no staining of perinuclear reticular networks indicative of the
ER or punctate cytoplasmic granular staining indicative of endosomes/
lysosomes. Taken together, the above results showed that newly
synthesized gp75∆27-LDL was transported out of the ER to the Golgi
apparatus with kinetics that mirrored those of wild-type gp75, but no
sorting to the endocytic compartment was evident.
DISCUSSION
Intracellular retention and sorting to different intracellular organelles
is directed by signals in the protein sequence. Proteins devoid of
retention signals are transported through the default pathway to the
cell surface or are secreted (Rothman, 1987). In this study we
investigated the requirements in the cytoplasmic tail of mouse gp75
for intracellular sorting and targeting from the ER to endocytic/
melanosomal compartments. The cytoplasmic tail of mouse gp75
contains an intracellular retention signal that is required for sorting to
the endocytic compartment: (i) deletion of 27 or 33 of the 36 amino
acids in the cytoplasmic tail led to cell surface expression; and (ii)
deletion of the entire cytoplasmic tail and 19 of the 24 amino acids in
the transmembrane domain resulted in secretion, with no intracellular
endosomal/lysosomal retention. These results are consistent with earlier
findings that the cytoplasmic tail of human gp75 contains an intracellular
retention and sorting signal, specifically the di-leucine containing
sequence Asn-Gln-Pro-Leu-Leu-Thr-Asp (Vijayasaradhi et al, 1995).
Because this sequence is conserved in mouse gp75, and the sequence
is deleted in gp75∆33 and gp75∆27 mutants, our results support the
view that this sequence is also the intracellular retention signal in
mouse gp75. The notion that tyrosinase family proteins might contain
a sorting signal in the cytoplasmic domain was originally proposed by
the group of Tchen based on sequence analysis of goldfish TRP1 that
showed conservation of homologous regions in the cytoplasmic tail
through vertebrate evolution (Peng et al, l994). Subsequent studies
from Beermann et al of the carboxyl truncated platinum (cp) allele of
the albino locus showed that the last 27 amino acids of mouse tyrosinase
were required for intracellular sorting from the Golgi, and that loss of
these amino acids allowed cell surface expression (Beermann et al,
1995). Other factors also influence sorting and localization. For instance,
studies of gp75/TRP-1 in homozygous brown mutation are not
completely glycosylated and do not reach the melanosomal
compartment (Orlow et al, 1993).
Recently, we found that B16 melanoma cells as well as human
melanoma cell lines express a very small proportion of gp75 on the
plasma membrane (Takechi et al, 1996; Xu et al, 1997). The plasma
membrane gp75 detected in B16 melanoma cells is full length,
presumably with the intact intracellular retention signal. Several
mechanisms have been proposed to explain the observation of plasma
membrane localization of full length gp75 (Xu et al, 1997). (i) Cell
surface gp75 may reflect a postendosome/melanosome targeting event
resulting from the fusion of melanosomal membranes with the plasma
membrane to transport melanin to the extracellular environment
(Moellmann et al, 1988; Vijayasaradhi et al, 1995). (ii) The plasma
membrane may serve as an intermediate transport step from the Golgi
apparatus to the melansomes. (iii) Transport to the cell surface could
be due to saturation of the melanosomal sorting pathway.
Immunofluorescence staining in situ of B16 cells did not detect cell
surface gp75, indicating that the level of natural cell surface expression
is below the limits of detection by this method.
In contrast, gp75∆33 and gp75∆27 showed predominant plasma
membrane expression pattern, with no intracellular vesicular staining,
although these studies are restricted to expression in mouse L cell
fibroblasts. This staining pattern showed that cell surface expression is
the predominant expression pattern for gp75 mutants lacking the
cytoplasmic sorting signal. These results also show that gp75 apparently
does not contain additional signals in the lumenal domain for
intracellular retention. Because the cytoplasmic tail contains an
endocytic sorting signal and determines export from and stability in
the ER, gp75 mutants that lack part or all of the cytoplasmic tail tend
to be retained in the ER for relatively rapid degradation. The minor
proportion of tailless gp75 that is able to exit the ER is not sorted to
the endocytic compartment, but rather follows the default pathway
(i.e., the default secretory pathway for proteins that lack sorting signals).
Mutant proteins gp75∆27, gp75∆33, and gp75∆55 were all retained
in the ER in transfected fibroblasts. ER retention as a result of deletion,
extension, or substitution of small peptides in the cytoplasmic tail has
been reported in classic studies of influenza hemagglutinin (Doyle et al,
1985, 1986; Gething et al, 1986; Copeland et al, 1988) and vesicular
stomatitis virus G protein (Rose and Doms, 1988). Two mechanisms
have been hypothesized for ER retention, involving either deletion of
a positive transport signal or alteration of protein folding leading to
unstable intermediate forms that are degraded in the ER. It has been
proposed that the ER is another cellular compartment for disposal of
proteins that are incorrectly folded or aggregated, and that the ER
regulates the export of these proteins through a quality control
mechanism (Klausner and Sitia, 1990; Hammond and Helenius, 1994).
It is known that malfolded proteins are held up in the ER by binding
to ER chaperones (Hurtley et al, 1989; Ou et al, 1993; Le et al, 1994;
Kim and Arvan, 1995; Ware et al, 1995); however, it is not clear how
deletion in the cytoplasmic tail (located on the cytosolic surface outside
the ER) may affect the folding or stability of the lumenal domain of
the protein. Sorting and concentration of glycoproteins can occur in
the ER before transport to the Golgi (Mizuno and Singer, 1993; Balch
et al, 1994), arguing that the ER to Golgi transport is an active process,
involving interactions between structural elements in the cytoplasmic
tail of the protein with transport machinery in the cytosol (Fiedler and
Simons, 1995). Evidence for positive transport signals out of the ER
combined with signals to retrieve proteins from the Golgi back to the
ER have been demonstrated (Rothman, 1987; Orci et al, 1997). One
potential signal for export from the ER, the diacidic residues Asp-X-
Glu, has been recently discovered in the cytoplasmic tails of vesicular
stomatitis virus G protein and lysosomal acid phosphatase (Nishimura
and Balch, 1997). This dipeptide motif presumably determines vesicular
transport from ER to Golgi by binding to COPII coat complexes that
segregate selected ER transmembrane proteins through cytoplasmic
signaling and budding from the ER membrane. Interestingly, this
diacidic motif is found near the carboxyl terminus of mouse gp75
(–11 to –13 residues upstream of the carboxyl terminus), but not in
human or tyrosinase. This potential ER export signal is found in all
our deletion mutants, including gp75∆27. Thus, this dipeptide motif
in gp75 likely determines export from the ER, and the ER retention
of the different deletion mutants of the cytoplasmic tail reflects loss of
this export signal. The diacidic signal in gp75 may account for its
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relatively rapid move from ER to Golgi, compared with the slow ER
to Golgi movement of tyrosinase (Vijayasaradhi et al, 1991).
Unexpectedly, the chimeric molecule, gp75∆27-LDL, which
contained an unrelated seven amino acid extension in the cytoplasmic
region, was efficiently transported from the ER at a rate comparable
with that of wild-type gp75 with no detectable ER retention. In
particular, the LDL receptor sequence does not contain the known
dipeptide ER export signal. One possibility is that any extension in
the cytoplasmic tail could restore stable transport out of the ER,
regardless of the specific sequence of the extension. In this scenario,
a minimal length of the cytoplasmic tail is required for vesicular
transport of a particular transmembrane protein; however, this does
not seem likely because gp75∆27-LDL contains only three more amino
acids than gp75∆27. More likely, the sequence Asn-Pro-Val-Tyr
(NPVY) in the LDL tail extension somehow permits ER export. This
sequence is in fact used for transport in a different circumstance.
Tyrosine based signals are used to sort transmembrane proteins from
the trans-Golgi network and the cell surface into the endocytic pathway
using clathrin as the coat complex. Specifically, NPVY signal is required
for internalization of the LDL receptor from the cell surface once it is
bound by LDL (Chen et al, 1990; Bansal and Gierasch, 1991). Thus,
presumably this tyrosine based motif can also direct export from the
ER, although the question remains whether clathrin or other coat
complexes are involved. An alternative explanation for ER retention
of gp75∆33 and gp75∆27 is that they are malfolded in the lumenal
domain. It is possible that malfolded gp75 is then degraded at an
accelerated rate in the ER, or that ER proteases degrade gp75 more
rapidly unrelated to malfolding. The gp75 variants retained in the ER
have a relatively shortened half-life, although they remain relatively
stable. A third possibility is that gp75 normally form homomeric or
heteromeric complexes, and the deletion in the cytoplasmic tail caused
disruption of the complex, leading to aggregation and retention of
monomers. Based on the results with the LDL tail extension of gp75,
we favor the first possibility that the LDL cytoplasmic tail contains an
ER export signal, rather than malfolding or formation of post-
transcriptional multimers.
The data on the kinetics of intracellular transport of gp75 has
immunologic implications. Gp75 is normally transported from the ER
to the Golgi by the end of 1 h after de novo synthesis; however, with
deletion of the cytoplasmic tail, a large proportion of gp75 is retained
and degraded in the ER with a half-life of 1–2 h. This could allow
generation of peptides in a compartment that intersects the major
histocompatibility complex class I antigen presentation pathway. This
also opens the possibility of using genes encoding truncated mutants
of melanosomal proteins for immunization to generate cytotoxic T cells
against peptides of tyrosinase family proteins by selective degradation of
the proteins in the ER.
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